Kalra, Jessica http://orcid.org/0009-0004-3383-6901
Baker, Jennifer
Sun, XuXin
Kyle, Alastair
Minchinton, Andrew
Bally, Marcel B.
Funding for this research was provided by:
Canadian Cancer Society (702491, 705290)
CIHR (MOP-102611)
Article History
Received: 27 February 2024
Accepted: 21 June 2024
First Online: 3 July 2024
Declarations
:
: Not applicable.
: The authors declare no competing interests.
: All animal studies were completed under A22-0274 (and the previously approved protocol A18-0276), an animal care protocol approved by the Institutional Animal Care Committee (IACC) at the University of British Columbia. The IACC for studies conducted at the BC Cancer Research Institution (BCCRI) is managed and run through the University of British Columbia. The studies completed are in accordance with the Canadian Council of Animal Care (CCAC).
: Patents protecting Irinophore C reached the international stage of filing, but these patents have since been abandoned.